Last reviewed · How we verify

NCT04393636: DCC

Digital Cardiac Counseling Trial: DCC Trial

Completed NA Last updated 8 July 2024
What this trial tests

NA trial testing Digital cardiac Counseling in Cardiovascular Diseases in 394 participants. Completed in 22 March 2024.

Timeline
5 June 2020
Primary endpoint
22 March 2024
22 March 2024

Quick facts

Lead sponsorAcademisch Ziekenhuis Maastricht
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment394
Start date5 June 2020
Primary completion22 March 2024
Estimated completion22 March 2024
Sites1 location across Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

Academisch Ziekenhuis Maastricht

Who can join

18 and older, any sex, with Cardiovascular Diseases or Cardiovascular Risk Factor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Most patients undergoing a cardiovascular procedure need an ICU-bed during the hospitalization and therefore it is possible that for the unforeseen future, because of the Covid-19 crisis, many patients will stay on the waiting list for many months to come. There are some studies showing an increased mortality associated with an increased waiting time for the patients on the waiting list for an elective cardiac surgery. However, there is no data on the evolution of the morbidity, the quality of life and the symptomatology of the patients waiting for an elective operation. Also it is not clear whether the period of waiting for an elective cardiovascular operation would impact the morbidity or the mortality of the planned operation at later stage. Furthermore, there is a plethora of studies on risk factors associated with the perioperative morbidity and mortality in general. Therefore, the rationale of the current study is to evaluate whether Digital Cardiac Counseling (DCC) would improve outcomes of the patients waiting for an elective cardiac operation. At the DCC platform, there will be assessments of cardiovascular symptoms, Covid-19 prevention for cardiovascular patients, smoking cessation, anxiety relief, exercise stimulation, pulmonary rehabilitation and diet adjustments. This will be done by means of questionnaires and E-consults.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. The Effect of Teleprehabilitation on Adverse Events After Elective Cardiac Surgery: A Randomized Controlled Trial.
    Scheenstra B, van Susante L, Bongers BC, Lenssen T, et al · · 2025 · cited 12× · PMID 39396714 · DOI 10.1016/j.jacc.2024.10.064
  2. Personalized teleprehabilitation in elective cardiac surgery: a study protocol of the Digital Cardiac Counselling randomized controlled trial.
    Scheenstra B, Mohansingh C, Bongers BC, Dahmen S, et al · · 2021 · cited 6× · PMID 36713609 · DOI 10.1093/ehjdh/ztab041
  3. Monitoring cardiac symptoms during teleprehabilitation prior to coronary artery bypass grafting: a digital cardiac counselling trial subanalysis.
    van Susante L, van Mierlo R, Scheenstra B, van 't Hof A, et al · · 2026 · PMID 42238294 · DOI 10.1093/ehjdh/ztag076

Verify or expand the search:

Other recruiting trials for Cardiovascular Diseases

Currently open trials in the same condition.

Other Academisch Ziekenhuis Maastricht trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04393636.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing